PROCEPT BioRobotics Corporation reported Q4 2024 revenue of $68.2M, missed analyst consensus of $76.0M by $7.7M. Diluted EPS came in at $-0.35, missed the $-0.34 consensus by $0.01.
Trailing eight quarters through Q4 2024
Common questions about PROCEPT BioRobotics Corporation's Q4 2024 earnings report.
PROCEPT BioRobotics Corporation (PRCT) reported Q4 2024 earnings on February 25, 2025 after market close.
PROCEPT BioRobotics Corporation reported revenue of $68.2M and diluted EPS of $-0.35 for Q4 2024.
Revenue missed the consensus estimate of $76.0M by $7.7M. EPS missed the consensus estimate of $-0.34 by $0.01.
You can read the 10-K periodic report (0001588978-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.